Literature DB >> 28981179

Sweet's syndrome: diagnostic criteria revisited.

Ahmad Nofal1, Ayman Abdelmaksoud2, Hala Amer3, Eman Nofal1, Ayman Yosef1, Khaled Gharib1, Waleed Albalat1, Fatma Eldesouky1, Howyda M Ebrahim1, Ahmed Said Abdelshafy1, Hala Fayed3.   

Abstract

The diagnosis of Sweet's syndrome (SS) is based on a set of criteria that requires the presence of two major and at least two minor criteria. In some cases, however, the diagnosis is not as straightforward due to the absence of certain criteria. The objective of the present study was to review the clinical, histopathological, and laboratory features of the current diagnostic criteria for SS, and to evaluate their validity in the cases reported in the literature as well as in 40 patients treated at our institution. Our comprehensive review of the current criteria for SS reveals that the two major criteria have been consistently present in all cases - including ours - since the first description of SS in 1964. With regard to the minor criteria, on the other hand, there has been marked variability between different studies, and many cases failed to fulfill the requirement of showing two minor criteria. In order to simplify the diagnosis, avoid misdiagnosis, and allow for prompt treatment, we propose two sets of revised diagnostic criteria for SS. The first set comprises constant clinical and histopathological features that must be present and are by themselves sufficient for the diagnosis of SS to be established. The second set includes variable features whose absence does not warrant ruling out SS.
© 2017 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28981179     DOI: 10.1111/ddg.13350

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  11 in total

1.  Sweet's Syndrome as Manifestation of Active Ulcerative Colitis.

Authors:  Mario Bento-Miranda; David N Perdigoto; Sofia Mendes; Francisco Portela
Journal:  GE Port J Gastroenterol       Date:  2019-08-06

2.  Minocycline-induced Sweet's syndrome.

Authors:  Shaun Khanna; Surjit Tarafdar
Journal:  Oxf Med Case Reports       Date:  2020-06-13

3.  Multiple painful plaques and the Sweet's syndrome.

Authors:  Debra Lee; Daniel Baird; Michelle Tarbox
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-09-30

4.  CD30+ Transformed Mycosis Fungoides Associated with Sweet-like Dermatosis.

Authors:  Florine André; Christa Prins; Michel Gillet; Emmanuella Guenova; Gabriela Blanchard
Journal:  Acta Derm Venereol       Date:  2022-03-31       Impact factor: 3.875

5.  Orofacial manifestations of SAPHO syndrome: a systematic review of case reports.

Authors:  Clémence Ferreira-Vilaca; Leonor Costa Mendes; Sophie-Caroline Campana; Isabelle Bailleul-Forestier; Christine Audouin-Pajot; Rémi Esclassan; Thibault Canceill
Journal:  Clin Rheumatol       Date:  2020-05-09       Impact factor: 2.980

6.  Targetoid Skin Lesions in a Child: Acute Hemorrhagic Oedema of Infancy and Its Differential Diagnosis.

Authors:  Francesco Miconi; Lorenzo Cassiani; Emanuela Savarese; Federica Celi; Manuela Papini; Nicola Principi; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2019-03-06       Impact factor: 3.390

7.  Neuro-Behçet Disease, Neuro-Sweet Disease, and Spectrum Disorders.

Authors:  Kinya Hisanaga
Journal:  Intern Med       Date:  2021-10-05       Impact factor: 1.271

8.  A rare case of Sweet syndrome secondary to melioidosis.

Authors:  Sahathevan Vithoosan; Balendran Thanushah; Paramarajan Piranavan; Dayal Gamlaksha; Harindra Karunatilake; Ananda Jayanaga
Journal:  BMC Dermatol       Date:  2019-12-02

9.  Vesiculobullous eruption in neutropenic patient with Crohn's disease.

Authors:  Jeanette Wat; Margaret Wat; Kord Honda
Journal:  JAAD Case Rep       Date:  2020-02-18

10.  Sweet Syndrome Associated with Ixazomib

Authors:  İrfan Yavaşoğlu; Zahit Bolaman
Journal:  Turk J Haematol       Date:  2021-06-11       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.